Rep. Warren Davidson Sells GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock

Representative Warren Davidson (Republican-Ohio) recently sold shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC). In a filing disclosed on March 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in GE HealthCare Technologies stock on March 23rd.

GE HealthCare Technologies Stock Down 0.9%

GE HealthCare Technologies stock opened at $71.54 on Friday. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $89.77. The stock has a market cap of $32.64 billion, a price-to-earnings ratio of 15.69, a PEG ratio of 1.59 and a beta of 1.03. The company’s 50-day moving average price is $78.16 and its two-hundred day moving average price is $78.33. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

Hedge Funds Weigh In On GE HealthCare Technologies

Several large investors have recently bought and sold shares of GEHC. Vanguard Group Inc. grew its stake in shares of GE HealthCare Technologies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after purchasing an additional 267,058 shares during the period. Auto Owners Insurance Co lifted its position in shares of GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after buying an additional 33,629,559 shares during the period. Dodge & Cox boosted its stake in GE HealthCare Technologies by 13.4% in the 4th quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after buying an additional 3,693,918 shares in the last quarter. Capital Research Global Investors boosted its stake in GE HealthCare Technologies by 1.6% in the 4th quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after buying an additional 389,796 shares in the last quarter. Finally, State Street Corp grew its position in GE HealthCare Technologies by 2.0% in the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after acquiring an additional 401,932 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

GEHC has been the subject of a number of research reports. Citigroup cut their price target on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a research note on Wednesday, March 11th. Morgan Stanley increased their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. Stifel Nicolaus raised their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. BTIG Research reiterated a “buy” rating and issued a $91.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, March 19th. Finally, Barclays boosted their target price on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Hold” and an average price target of $92.17.

About Representative Davidson

Warren Davidson (Republican Party) is a member of the U.S. House, representing Ohio’s 8th Congressional District. He assumed office on June 9, 2016. His current term ends on January 3, 2027.

Davidson (Republican Party) ran for re-election to the U.S. House to represent Ohio’s 8th Congressional District. He won in the general election on November 5, 2024.

Davidson received his undergraduate degree from West Point and his MBA from Notre Dame. He served in the Old Guard, 75th Ranger Regiment and 101st Airborne Division of the U.S. Army.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.